市场调查报告书
商品编码
1250710
全球医用泡沫市场:到 2028 年的预测——按泡沫类型、材料(聚烯烃、聚苯乙烯、聚氨酯、PVC 等)、应用和地区分析Medical Foam Market Forecasts to 2028 - Global Analysis By Form Type, Material (Polyolefin, Polystyrene, Polyurethane, Polyvinyl chloride and Other Materials), Application and By Geography |
据 Stratistics MRC 预计,2022 年全球医用泡沫市场规模将达到 280.9 亿美元,2028 年将达到 484.3 亿美元,复合年增长率为 9.5%。
医用泡沫与其他通用泡沫完全不同,专为医疗行业中各种具有挑战性的应用而配製,具有生物相容性、无毒性、低颗粒物和无菌性。 医用泡沫在医疗领域发挥着最重要的作用,因为它们具有很高的耐污染性,可以有效地实现洁净室的抗菌应用。 这降低了医院常见的疾病和细菌传播的风险。
根据世界贸易组织 (WTO) 的数据,医疗产品在全球贸易中的份额从 2019 年的 5.3% 增加到 2020 年的 6.6%。 2020 年,口罩、手套等抗疫物资的全球贸易增长了 31%。 预计这将显着增加医用泡沫的市场规模。
在脊柱植入物中采用医用泡沫
由于医用泡沫具有出色的强度重量比、出色的生物相容性、卓越的性能和成本效益等广泛的特性,因此越来越受欢迎并扩大了脊柱植入物的市场。. 例如,Xenco Medical 宣布于 2020 年 6 月在全国推出 CancelleX 仿生脊柱植入物。 该植入物是第一个注射成型并预装在一次性器械中的钛泡沫脊柱植入物。 Xenco Medical 的 CancelX Lumbar Intrabody 率先使用注塑成型製造钛脊柱植入物。 此类产品的推出加速了医疗泡沫市场的增长,并在预测期内推动了同一细分市场的增长。
原材料价格的变化
原材料的差异预计将成为全球医疗泡沫市场的最大障碍。 原油决定苯的价格,价格大幅波动会导致亏损。 聚苯乙烯泡沫塑料的成本受苯乙烯等原材料成本的影响。 此类变化可能会影响市场竞争对手的盈利能力,从而阻碍市场增长。
政府对医疗保健的投资
全球医用泡沫市场的扩张受到许多因素的推动,包括人口老龄化、医疗保健成本上升以及医疗行业的快速增长。 此外,政府增加对医疗保健行业的投资正在推动医用泡沫行业的扩张。 此外,世界上不断增长的人口和消费者对健康和清洁的关注正在增加对可用于各种应用的高质量医用泡沫的需求。
严格的规章制度
在预测期内,市场增长预计将受到医疗保健行业严格法规实施的限制,以确保最高标准的包装和标籤服务。 测试和完整性程序适用于所有类型的医疗包装,以确保符合製药行业製定的标准和法规。 医疗包装选项和设备必须能够承受苛刻的消毒剂和各种灭菌过程。 因此,由于严格的规章制度,医用泡沫行业面临着巨大的困难和放缓。
COVID-19 大流行对全球经济产生了负面影响,这些国家/地区的 GDP 有所下降。 这将改变全球消费者的消费模式。 由于 COVID-19 感染的增加,更多的患者被送往医院。 患有严重 COVID-19 感染的人将需要呼吸器来控制感染。 这是增加医用泡沫在麻醉和呼吸支持中的使用的一个主要因素。
预计在预测期内,灵活表单部分将成为最大的部分
预计软质泡沫将主导医用泡沫市场,并在预测期内占据最大份额。 这一市场增长是由于软质泡沫在床上用品和垫子、伤口敷料和医疗包装等应用中的使用越来越多。 由于其独特的性能,医用软质泡沫也适用于广泛的应用。
聚烯烃领域预计在预测期内表现出最高的复合年增长率
聚烯烃预计在预测期内增长最快,因为它们通常用于医疗保健行业的医疗包装和组件。 聚烯烃具有优良的隔热和阻尼性能,因此常被用来包裹精密的设备和仪器。 此外,易于製造和高负载能力允许生产商使用更薄的泡沫,数量更少,从而降低包装成本。 像这样的点正在推动这个细分市场的扩张。
市场份额最高的地区
由于美国人均医疗保健支出不断增加,预计在预测期内北美将主导市场并占据最大份额。 因此,该地区对医用泡沫的需求可能会增加。 影响北美市场的主要趋势之一是美国健康保险形式的人均医疗支出增加。 在接下来的几年里,对仿製药和医疗器械的需求预计将增长,从而推动该地区的市场。
在预测期内,亚太地区医疗泡沫的市场规模预计将以最高复合年增长率增长。 推动该地区医疗泡沫市场扩张的主要因素是医院的扩张、医疗旅游业的发展以及老年人口的增加。 此外,亚太地区的主要公司生产适合伤口癒合的医用泡沫,同时考虑到伤口大小、位置、持续时间和深度等许多变量。
2022 年 1 月,UFP Technologies 宣布收购医疗设备合同製造商 DAS Medical。 金额尚未披露。
2021 年 2 月,Nexus Spine 宣布推出一款脊柱植入物。 Nexus Spine 推出了用于人体脊柱稳定的患者专用固定係统 PressOn 和用于躯干间固定的柔性钛设备 Tranquil。
2020 年 6 月,Xenco Medical 宣布在全国推出 CancelleX 仿生脊柱植入物,这是首款预装在一次性器械中的注塑成型泡沫钛脊柱植入物。
购买此报告的客户将免费获得以下定制之一。
According to Stratistics MRC, the Global Medical Foam Market is accounted for $28.09 billion in 2022 and is expected to reach $48.43 billion by 2028 growing at a CAGR of 9.5% during the forecast period. Medical grade foams are quite different from any other commodity foams in that they are specially formulated for a variety of difficult applications in the medical industry and are rated biocompatible, non-toxic, low particulate, and sterilized. Due to their contaminant resistance and ability to effectively clean rooms for anti-bacterial applications, these medical grade foams prove to be of utmost importance for the medical sector. This lowers the risk of illness and the spread of germs, which is quite common in hospitals.
According to the World Trade Organisation, Medical goods' share in global commerce increased from 5.3% in 2019 to 6.6% in 2020. Global trade in pandemic-fighting goods such as face masks, gloves increased by 31% in 2020. Which is predicted to make a significant contribution to the medical foam market size.
Adoption of medical foam in spinal implants
The market for medical foam is expanding as it becomes more frequently used in spinal implants and of its extensive properties, which include a remarkable strength-to-weight ratio, excellent biocompatibility, superior performance, and cost effectiveness. For instance, Xenco Medical announced the nationwide launch of CancelleX Bio-inspired Spinal Implants in June 2020. These implants are the first titanium foam spine implants that have been injection-molded and pre-attached to disposable instruments. The CancelleX lumbar intrabodies from Xenco Medical are a pioneer in the use of injection molding in the production of titanium spinal implants. Such product introductions are accelerating the growth of the medical foam market, propelling the sector's growth over the forecast period.
Fluctuations of raw material prices
Variations in raw materials are anticipated to be the biggest barrier to the global market for medical foam, according to the report. Crude oil sets the price of benzene, and significant price swings could lead to losses. The cost of polystyrene foam is influenced by the cost of styrene and other raw materials. By affecting the profitability of market competitors, such changes are likely to impede market growth.
Government investments in the healthcare sector
Numerous factors, including the aging population, rising global health expenditures, and the quickening growth of the medical sector, are cited for the expansion of the medical foam market worldwide. Additionally, the growing government investments in the healthcare sector are fueling the expansion of the medical foam industry. Furthermore, the growing global population and consumer focus on health and regular cleanliness are driving up demand for high-quality medical foam that can be used in a variety of applications.
Stringent rules and regulations
During the forecast period, market growth is anticipated to be constrained by the implementation of strict regulations in the healthcare sector to guarantee the highest standards of packaging and labeling services. To ensure compliance with standards and regulations set by the pharmaceutical industry, testing and integrity-related procedures are applied to all kinds of medical packaging. Medical packaging options and equipment must withstand harsh disinfectants and various sterilization processes. Therefore, the medical foam industry faces significant difficulties and a slowdown as a result of the strict rules and regulations.
The COVID-19 pandemic had a negative impact on the world economy, which is causing GDP in those economies to decline. This will change consumer spending patterns around the world. Because of the rise in COVID-19 infections, there are more patients being admitted to hospitals. People who have COVID-19 infections that are severe need breathing apparatus to manage their infections. This is a significant contributing factor to the increased use of medical foam in the support of anesthesia and breathing apparatus.
The flexible foam segment is expected to be the largest during the forecast period
The flexible foam segment dominated the medical foam market and is predicted to witness largest share during the forecast period. The expansion of this market can be attributed to the growing use of flexible foam in applications such as bedding and cushioning, wound dressing, and medical packaging. Additionally, flexible medical foam is well suited for use in a variety of applications due to its distinctive properties.
The polyolefin segment is expected to have the highest CAGR during the forecast period
Due to its expanding use in medical packaging and components in the healthcare sector, polyolefin is anticipated to experience the fastest growth over the forecast period. As a result of their excellent insulation and vibration-dampening qualities, they are frequently used for packaging delicate instruments and devices. Additionally, because it is simple to make and has a high load-bearing capacity, producers can use less and thinner foam, lowering the cost of packaging. Such aspects are boosting the segment's expansion.
Region with largest share:
North America dominated the market and is expected to hold largest share over the forecast period due to the rising per capita health expenditure in the U.S. The demand for medical foam in the area is probably going to increase as a result. One of the key trends affecting the market in North America is the rise in per capita healthcare spending in the United States, which takes the form of health insurance. Over the ensuing years, this is anticipated to increase demand for both generic medications and medical equipment, driving the regional market.
The Asia-Pacific medical foam market size is projected to grow at the highest CAGR during the forecast period. The main factors driving the expansion of the medical foam market in this region are the expansion of hospitals, the development of the medical tourism industry, and the rise in the number of elderly people. Moreover, number of variables, including wound size, location, duration, and depth, are taken into account by major players in the Asia-Pacific region in order to manufacture medical foam that is appropriate for treating wounds.
Some of the key players profiled in the Medical Foam Market include 3M, Armacell International Holding GmbH, Avery Dennison Corp., BASF SE, Foamtec Medical, Freudenberg Group, FXI Holdings, Inc., General Plastics Manufacturing Company, Inc., Huntsman International LLC., INOAC Corporation, Molnlycke Health Care, Recticel NV, Rogers Corporation, Sekisui Chemical Co., Ltd., The Dow Chemical Company, Trelleborg AB, UFP Technologies, Inc. and Zotefoams plc.
In January 2022, UFP Technologies announced the acquisition of medical device contract manufacturer DAS Medical. The amount was not disclosed.
In February 2021, Nexus Spine introduced spinal implants. Nexus Spine debuted its PressOn patient-specific fixation system for human spine stabilization, as well as its Tranquil flexible titanium device for interbody fusion.
In June 2020, Xenco Medical Announced the Nationwide Launch of CancelleX Bio-inspired Spinal Implants, the First Injection-Molded Titanium Foam Spinal Implants Pre-Attached to Disposable Instruments.
Form Types Covered:
Materials Covered:
Applications Covered:
Regions Covered:
All the customers of this report will be entitled to receive one of the following free customization options: